Multi-purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed-absorption H Kadry, TA Al-Hilal, A Keshavarz, F Alam, C Xu, A Joy, F Ahsan International journal of pharmaceutics 544 (1), 285-296, 2018 | 143 | 2018 |
Oral drug delivery systems using chemical conjugates or physical complexes TA Al-Hilal, F Alam, Y Byun Advanced drug delivery reviews 65 (6), 845-864, 2013 | 113 | 2013 |
Engineered nanodelivery systems to improve DNA vaccine technologies M Lim, AZM Badruddoza, J Firdous, M Azad, A Mannan, TA Al-Hilal, ... Pharmaceutics 12 (1), 30, 2020 | 94 | 2020 |
Strategies for non-invasive delivery of biologics SW Chung, TA Hil-lal, Y Byun Journal of drug targeting 20 (6), 481-501, 2012 | 62 | 2012 |
High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives JW Park, OC Jeon, SK Kim, TA Al-Hilal, SJ Jin, HT Moon, VC Yang, ... Journal of controlled release 148 (3), 317-326, 2010 | 62 | 2010 |
Functional transformations of bile acid transporters induced by high-affinity macromolecules TA Al-Hilal, SW Chung, F Alam, J Park, KE Lee, H Jeon, K Kim, IC Kwon, ... Scientific reports 4 (1), 4163, 2014 | 55 | 2014 |
Oligomeric bile acid-mediated oral delivery of low molecular weight heparin TA Al-Hilal, J Park, F Alam, SW Chung, JW Park, K Kim, IC Kwon, IS Kim, ... Journal of controlled release 175, 17-24, 2014 | 55 | 2014 |
Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid F Alam, TA Al-Hilal, SW Chung, D Seo, F Mahmud, HS Kim, SY Kim, ... Biomaterials 35 (24), 6543-6552, 2014 | 51 | 2014 |
Antiangiogenic and anticancer effect of an orally active low molecular weight heparin conjugates and its application to lung cancer chemoprevention J Kim, TA Al-Hilal, SW Chung, SY Kim, GH Ryu, WC Son, Y Byun Journal of controlled release 199, 122-131, 2015 | 43 | 2015 |
LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways SW Chung, SM Bae, M Lee, TA Al-Hilal, CK Lee, JK Kim, IS Kim, SY Kim, ... Biomaterials 37, 271-278, 2015 | 42 | 2015 |
Transplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis JY Shin, JH Jeong, J Han, SH Bhang, GJ Jeong, MR Haque, TA Al-Hilal, ... Tissue Engineering Part A 21 (5-6), 1024-1035, 2015 | 38 | 2015 |
Xenotransplantation of layer-by-layer encapsulated non-human primate islets with a specified immunosuppressive drug protocol MR Haque, J Kim, H Park, HS Lee, KW Lee, TA Al-Hilal, JH Jeong, ... Journal of Controlled Release 258, 10-21, 2017 | 37 | 2017 |
Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates OC Jeon, SR Hwang, TA Al-Hilal, JW Park, HT Moon, S Lee, JH Park, ... Pharmaceutical research 30, 959-967, 2013 | 36 | 2013 |
Cancer-on-a-chip: models for studying metastasis X Zhang, M Karim, MM Hasan, J Hooper, R Wahab, S Roy, TA Al-Hilal Cancers 14 (3), 648, 2022 | 32 | 2022 |
Pulmonary-arterial-hypertension (PAH)-on-a-chip: fabrication, validation and application TA Al-Hilal, A Keshavarz, H Kadry, B Lahooti, A Al-Obaida, Z Ding, W Li, ... Lab on a Chip 20 (18), 3334-3345, 2020 | 30 | 2020 |
Anticoagulant efficacy of solid oral formulations containing a new heparin derivative JW Park, OC Jeon, SK Kim, TA Al-Hilal, HT Moon, CY Kim, Y Byun Molecular pharmaceutics 7 (3), 836-843, 2010 | 30 | 2010 |
A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway JU Choi, SW Chung, TA Al-Hilal, F Alam, J Park, F Mahmud, JH Jeong, ... Biomaterials 139, 56-66, 2017 | 29 | 2017 |
Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine F Mahmud, OC Jeon, TA Al-Hilal, S Kweon, VC Yang, DS Lee, Y Byun Molecular Pharmaceutics 12 (6), 1911-1920, 2015 | 29 | 2015 |
Targeting prion-like protein doppel selectively suppresses tumor angiogenesis TA Al-Hilal, SW Chung, JU Choi, F Alam, J Park, SW Kim, SY Kim, ... The Journal of clinical investigation 126 (4), 1251-1266, 2016 | 27 | 2016 |
Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis SR Hwang, DH Seo, TA Al-Hilal, OC Jeon, JH Kang, SH Kim, HS Kim, ... Journal of controlled release 163 (3), 374-384, 2012 | 27 | 2012 |